Jazmin Azócar
Chilean molecular biologist democratizing genetic testing in Latin America
Jazmin Azócar, through her startup Bioscience, developed Latin America's first affordable hereditary cancer detection kit. Her CRISPR-based technology reduced testing costs by 80% compared to international alternatives, making genetic screening accessible across socioeconomic levels.
Key achievements include:
| • | Diagnosed 2,500+ patients in remote Andean communities |
| • | Developed portable lab equipment for rural clinics |
| • | Trained 300+ local healthcare workers in genetic counseling |
Azócar's work addresses critical gaps: 1) Latin America has 562 cancer geneticists for 650 million people vs. North America's 5,000 specialists. 2) Existing tests cost 3-5 months' average salary. Her „Kit del Pueblo“ (People's Kit) changed this paradigm through localized R&D and manufacturing.
Recognition includes MIT Technology Review's 35 Under 35 and Chile's National Innovation Award. Unlike traditional biotech models focused on wealthy markets, Azócar proves advanced medicine can prioritize accessibility without sacrificing quality. Current projects involve AI-powered early detection algorithms adapted for Latin American genetic diversity.
Literary Appearances
No literary records found
Cinematic Appearances
No cinematic records found